Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases.

Cristina BosettiClaudia SantucciLuca PasinaIda FortinoLuca MerlinoOscar CorliAlessandro Nobili

Published in: Pharmacoepidemiology and drug safety (2021)

These findings support the need for an appropriate drug review and improvement in the quality of drug prescription for vulnerable populations at the end-of-life.

Keyphrases

drug induced
papillary thyroid
multiple sclerosis
physical activity
adverse drug
emergency department
squamous cell carcinoma
quality improvement
young adults
lymph node metastasis
electronic health record